Bristol-Myers Squibb Other Noncash Income (Expense) increased by 93.2% to -$21.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 320.0%, from -$5.00M to -$21.00M.
Large fluctuations may indicate one-time accounting adjustments or non-recurring non-cash events that require further investigation.
This category aggregates various non-cash items that do not fit into standard categories like depreciation or stock-base...
Standard line item in cash flow statements; peers use this to capture miscellaneous non-cash accounting impacts.
operating_other_noncash_income_expense| Q2 '21 | Q1 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$2.00M | -$256.00M | -$44.00M | -$4.00M | $13.00M | -$269.00M | -$40.00M | -$23.00M | -$103.00M | -$5.00M | $7.00M | $74.00M | -$308.00M | -$21.00M |
| QoQ Change | — | <-999% | +82.8% | +90.9% | +425.0% | <-999% | +85.1% | +42.5% | -347.8% | +95.1% | +240.0% | +957.1% | -516.2% | +93.2% |
| YoY Change | — | — | — | +98.4% | — | — | +9.1% | -475.0% | +61.7% | +78.3% | — | +171.8% | — | -320.0% |